Nuclear Receptor Related 1 is a protein that nurr1 is an orphan nuclear receptor with ligand-independent activity:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
NURR1 is a member of the nuclear receptor superfamily:
- N-terminal AF-1 domain: Constitutive transcriptional activation
- DNA-binding domain (DBD): Two C4-type zinc fingers
- Hinge region: Flexible linker between DBD and LBD
- Ligand-binding domain (LBD): Responsible for dimerization and cofactor binding
- C-terminal AF-2 domain: Ligand-dependent activation function
NURR1 binds DNA as a monomer or dimer and regulates gene expression without classical ligand activation.
NURR1 is an orphan nuclear receptor with ligand-independent activity:
- Midbrain development: Essential for development of dopaminergic neurons
- DA neuron maintenance: Maintains dopaminergic neuron identity and function
- Tyrosine hydroxylase regulation: Directly activates TH and AADC expression
- Survival factors: Promotes expression of neurotrophic factors
- Transcriptional activator: Binds NGFI-B response elements (NBRE)
- Retrotransposon suppression: Represses LINE-1 retrotransposons in neurons
- Anti-inflammatory: Represses inflammatory gene expression
- Metabolic regulation: Affects glucose and lipid metabolism
- Cell cycle: Modulates cell proliferation and differentiation
- Neuroprotection: Promotes neuronal survival
NURR1 is critical in PD pathogenesis:
- Dopaminergic neuron loss: Reduced NURR1 contributes to SNc degeneration
- Gene mutations: NR4A2 mutations cause familial PD
- Therapeutic target: NURR1 agonists being developed
- Transcription dysregulation: Alters expression of DA-specific genes
- Motoneuron maintenance: Important for spinal cord motoneuron survival
- Gene expression: Alters expression in ALS models
- Therapeutic potential: NURR1 activation may protect motoneurons
- Striatal neuron survival: Protects medium spiny neurons
- Transcription regulation: Corrects dysregulated gene expression
- Neuroprotection: NURR1 overexpression improves phenotype
- Cognitive function: Associated with learning and memory
- Neuroinflammation: Modulates inflammatory responses
- Therapeutic potential: Being investigated for AD treatment
- NURR1 agonists: Cytosporone B and synthetic analogs
- Gene therapy: AAV-mediated NURR1 expression
- Epigenetic modulators: HDAC inhibitors increase NURR1 expression
- Combination approaches: NURR1 + BDNF co-therapy
- Zetterstrom et al., Nurr1 is essential for the development of midbrain dopaminergic neurons (1996)
- Le et al., Mutations in NR4A2 cause familial Parkinson's disease (2003)
- Jankovic et al., Nurr1 in Parkinson's disease: Therapeutic potential (2015)
- Kim et al., NURR1 and retinoic acid receptor signaling in neurodegeneration (2020)
- Zhang et al., NURR1: A potential therapeutic target for neurodegenerative diseases (2022)